Dr. Mohammed Bukari

Claim this profile

Community Cancer Institute

Studies Immune Thrombocytopenic Purpura
Studies Burkitt Lymphoma
5 reported clinical trials
22 drugs studied

Area of expertise

1Immune Thrombocytopenic Purpura
Mohammed Bukari has run 2 trials for Immune Thrombocytopenic Purpura.
2Burkitt Lymphoma
Mohammed Bukari has run 2 trials for Burkitt Lymphoma. Some of their research focus areas include:
CD22 positive
Philadelphia chromosome/BCR-ABL1 negative

Affiliated Hospitals

Image of trial facility.
Community Cancer Institute
Image of trial facility.
UCSF Fresno

Clinical Trials Mohammed Bukari is currently running

More about Mohammed Bukari

Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mohammed Bukari has experience with
  • Ianalumab
  • Placebo
  • Inotuzumab Ozogamicin
  • Azacitidine
  • Decitabine
  • Venetoclax

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mohammed Bukari specialize in?
Is Mohammed Bukari currently recruiting for clinical trials?
Are there any treatments that Mohammed Bukari has studied deeply?
What is the best way to schedule an appointment with Mohammed Bukari?
What is the office address of Mohammed Bukari?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security